Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 801,090 | 810,421 | 826,142 | 777,707 | 720,938 |
| Cost of Goods | 344,669 | 337,500 | 336,834 | 306,925 | 311,436 |
| Gross Profit | 456,421 | 472,921 | 489,308 | 470,782 | 409,502 |
| Operating Expenses | 257,899 | 247,459 | 230,889 | 224,085 | 224,843 |
| Operating Income | 199,191 | 225,962 | 259,253 | 247,622 | 185,095 |
| Interest Expense | 7,477 | 7,134 | 7,613 | 7,584 | 7,828 |
| Other Income | 169 | 122 | 91 | 52 | 169 |
| Pre-tax Income | 191,883 | 218,950 | 251,731 | 240,090 | 177,436 |
| Income Tax | 29,112 | 43,772 | 49,125 | 35,801 | 2,478 |
| Net Income Continuous | 162,771 | 175,178 | 202,606 | 204,289 | 174,958 |
| Minority Interests | N/A | -57 | 24 | 32 | 168 |
| Net Income | $162,771 | $175,235 | $202,582 | $204,257 | $174,790 |
| EPS Basic Total Ops | 1.92 | 2.06 | 2.37 | 2.39 | 2.05 |
| EPS Basic Continuous Ops | 1.92 | 2.06 | 2.37 | 2.39 | 2.05 |
| EPS Diluted Total Ops | 1.88 | 2.03 | 2.34 | 2.35 | 2.01 |
| EPS Diluted Continuous Ops | 1.89 | 2.02 | 2.34 | 2.35 | 2.01 |
| EBITDA(a) | $226,886 | $252,429 | $284,630 | $272,679 | $209,656 |